Technical analysis of Agenus Inc. (AGEN): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Agenus Inc. is a clinical-stage biotechnology firm operating globally, dedicated to the discovery and development of immuno-oncology therapies. The company's innovative technological arsenal includes Retrocyte Display, a sophisticated antibody expression platform designed to identify fully human and humanized monoclonal antibodies, alongside other proprietary display technologies.
Price Performance
| 1 month | -4.25% |
| 3 months | +140.33% |
| Year-to-date | +129.62% |
| 1 year | +58.46% |
| 3 years | -71.16% |
| 5 years | -93.82% |
52-Week Range
| 52-week High | $8.85 |
| 52-week Low | $2.71 |
| Avg Volume (90d) | 3.2M |
Technical Indicators
| SMA 50 | $6.81 |
| SMA 200 | $4.32 |
| Beta | 1.61 |
| 30-day Volatility (annualised) | 79.5% |
| Price vs SMA 50 | +5.9% |
| Price vs SMA 200 | +66.7% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $3.97 | |
| 2025-11 | $4.56 | +14.9% |
| 2025-12 | $3.14 | -31.1% |
| 2026-01 | $2.84 | -9.6% |
| 2026-02 | $3.33 | +17.3% |
| 2026-03 | $3.34 | +0.3% |
| 2026-04 | $3.91 | +17.1% |
| 2026-05 | $3.50 | -10.5% |
| 2026-06 | $3.06 | -12.6% |
| 2026-07 | $7.50 | +145.1% |
| 2026-08 | $7.61 | +1.5% |
| 2026-09 | $7.21 | -5.3% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $7.21 |
| Market Cap | $300M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| P/E Ratio | 2.68 |
| Price / Book | -1.51 |
| EV / EBITDA | 2.34 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | -0.20 |
| Current Ratio | 0.34 |